(Now Full) Healthy Volunteers Required for Flu Vaccine Study
Please note: This trial has finished recruiting and is not accepting new participants.
The purpose of this study is to learn about the safety (how well your body tolerates the vaccine) of the NovaFlu™ and NovaFlu-Q™ vaccines, and what dose of vaccine will give the best response. The vaccine is given as a single injection (or shot) in the muscle of your upper arm. Your body will treat the vaccine as a flu germ and make an immune response against it by producing protective blood proteins called “antibodies.” The amount of antibodies that your body makes in response to the vaccine can be measured by a blood test. Although it has not yet been proven, it is believed that the antibodies made by your body after vaccination with the NovaFlu™ or NovaFlu-Q™ vaccine will prevent flu illness and symptoms caused by the flu germs.
Participants will need to attend the research unit for 3 visits (a total of approximately 3 to 3.5 hours), and complete 3 telephone calls (approximately 10 to 20 minutes each).
Benefits to Participation
- Participants’ current state of health will be assessed and monitored by qualified health professionals.
- Participants will be compensated for travelling to the Research Centre 3 times and completing the study.
- Participants will be helping to advance medical research.
- Your records relating to this study and any other information received will be kept strictly confidential.
- If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
Who Can Participate?
- Males and Females aged 18 to 64 whom are generally healthy
- Are able to attend 3 visits to Holdsworth House Medical Practice over 6 months
- Participants must not have had a flu vaccine in the past 6 months
- Participants must not have current asthma
- Participants must not have diabetes